Regulation of Osteoblast Metabolism by Wnt Signaling.
10.3803/EnM.2018.33.3.318
- Author:
Megan C MOORER
1
;
Ryan C RIDDLE
Author Information
1. Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. rriddle1@jhmi.edu
- Publication Type:Review
- Keywords:
Wnt signaling;
Beta catenin;
Osteoblasts;
Intermediary metabolism
- MeSH:
Anabolic Agents;
beta Catenin;
Bone Development;
Bone Matrix;
Clone Cells;
Cloning, Organism;
Fatty Acids;
Glucose;
Glutamine;
Lipoproteins;
Metabolism*;
Osteoblasts*;
Sirolimus
- From:Endocrinology and Metabolism
2018;33(3):318-330
- CountryRepublic of Korea
- Language:English
-
Abstract:
Wnt/β-catenin signaling plays a critical role in the achievement of peak bone mass, affecting the commitment of mesenchymal progenitors to the osteoblast lineage and the anabolic capacity of osteoblasts depositing bone matrix. Recent studies suggest that this evolutionarily-conserved, developmental pathway exerts its anabolic effects in part by coordinating osteoblast activity with intermediary metabolism. These findings are compatible with the cloning of the gene encoding the low-density lipoprotein related receptor-5 (LRP5) Wnt co-receptor from a diabetes-susceptibility locus and the now well-established linkage between Wnt signaling and metabolism. In this article, we provide an overview of the role of Wnt signaling in whole-body metabolism and review the literature regarding the impact of Wnt signaling on the osteoblast's utilization of three different energy sources: fatty acids, glucose, and glutamine. Special attention is devoted to the net effect of nutrient utilization and the mode of regulation by Wnt signaling. Mechanistic studies indicate that the utilization of each substrate is governed by a unique mechanism of control with β-catenin-dependent signaling regulating fatty acid β-oxidation, while glucose and glutamine utilization are β-catenin-independent and downstream of mammalian target of rapamycin complex 2 (mTORC2) and mammalian target of rapamycin complex 1 (mTORC1) activation, respectively. The emergence of these data has provided a new context for the mechanisms by which Wnt signaling influences bone development.
